According to TScan Therapeutics's latest financial reports the company's current earnings are $12.2 Million USD. In 2023 the company made an earning of -$89.22 Million USD a decrease over its 2022 earnings that were of -$66.23 Million USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.